JOHN DEYOUNG is listed as a director on 1 SEC Form D filing by 1 issuer in Apr 2018: Allogene Therapeutics, Inc. (South San Francisco, CA — biotechnology — 2018; $411.8M reported sold to 23 investors).
What this means One deal on file with the SEC, filed Apr 2018. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Arie Belldegrun (1 shared filing), David Bonderman (1 shared filing), David Chang (1 shared filing), David M. Tanen (1 shared filing), Franz Humer (1 shared filing) and 4 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around JOHN. Each name links to their own page.
The issuer belongs to the sponsor group Tishman Speyer (120 issuers, $6.66B reported sold, 2009–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Tishman Speyer has 120 companies on file and $6.66B reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 3 bankruptcy cases matching the name listed in Key records below.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for JOHN DEYOUNG and found 3 differences: Bankruptcy case: Richard C. Breeden, Esq. v. Tanen; Same name, different state: "John DeYoung" (CO) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.